Baichuan AI is a Beijing-based large language model company building foundation models, an AI assistant and vertical solutions, with a particular emphasis on medical and professional knowledge applications in the Chinese market. The company has positioned itself as one of China's leading independent LLM developers alongside peers such as Moonshot AI, Zhipu and MiniMax.
Baichuan has released more than a dozen large language models under names such as Baichuan-7B, Baichuan-13B and Baichuan4, mixing open-source releases with enterprise-grade commercial models. In May 2024, it launched Baixiaoying, an AI assistant aimed at consumer and professional users. The company has also invested heavily in medical AI, viewing healthcare as a high-impact applied vertical.
Baichuan was founded in April 2023 by Wang Xiaochuan, the former CEO of Sogou (once China's second-largest search engine). The company is headquartered in Beijing and has rapidly built one of China's most well-resourced AI research teams.
In July 2024, Baichuan closed a roughly $691 million Series A round at a valuation of approximately $2.7 billion. The round was backed by Alibaba, Tencent and Xiaomi, alongside state-linked investors including China International Capital Corporation, AI industrial funds backed by the Beijing and Shanghai municipal governments and Shenzhen Capital Group. This places Baichuan among China's most valuable AI startups, second only to Moonshot AI at the time of the round.
Baichuan differentiates through its strategic focus on Chinese-language LLMs, a dedicated push into medical AI, strong commercial and political backing, and the credibility of its founder-CEO. Risks include intensifying competition among Chinese LLM builders, U.S. export controls on advanced AI chips and the broader regulatory environment for foundation models in China.